Imaging of Intravenous (IV) Combidex to Brain, Intra-cerebral Tumors and in Central Nervous System (CNS) Inflammation

NCT00659334 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

116

Enrollment

OTHER

Sponsor class

Stopped AMAG not continuing with Combidex, the study drug

Conditions

Brain Neoplasms

Interventions

DRUG: Ferumoxtran-10 (Combidex)
PROCEDURE: Neurosurgery

Sponsor

OHSU Knight Cancer Institute

Collaborators

[object Object]
[object Object]